| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥388.1B | ¥419.8B | -7.5% |
| Operating Income | ¥38.3B | ¥40.6B | -5.7% |
| Ordinary Income | ¥48.5B | ¥50.1B | -3.3% |
| Net Income | ¥45.9B | ¥40.0B | +14.7% |
| ROE | 9.9% | 8.9% | - |
FY2025 Q3 cumulative results show revenue of 38.81B yen (YoY -7.5%), operating income of 3.83B yen (YoY -5.7%), ordinary income of 4.85B yen (YoY -3.3%), and net income of 4.59B yen (YoY +14.7%). The company experienced revenue contraction primarily driven by consolidation changes in the China segment, where two subsidiaries were deconsolidated and converted to equity-method affiliates during Q1. Despite top-line pressures, net income improved significantly due to investment securities sales gains of 1.33B yen recorded as extraordinary income. Operating margin remained resilient at 9.9%, while net margin expanded to 11.8% supported by non-operating and extraordinary items. The divergence between operating performance (declining) and bottom-line results (improving) reflects substantial contribution from one-time factors rather than core business momentum.
Revenue declined 3.18B yen (YoY -7.5%) to 38.81B yen, driven primarily by structural changes in the China segment where consolidation scope narrowed. The China business contracted from 4.73B yen to 1.49B yen (YoY -68.6%) as Shanghai Yushiro Chemical Industry Co. and Rudong Yushiro Chemical Industry Co. were deconsolidated and converted to equity-method affiliates, with only Q1 results from Shanghai Yushiro included in consolidated figures. North and South America segment revenue decreased modestly from 17.14B yen to 16.85B yen (YoY -1.7%), while Japan segment revenue increased from 14.75B yen to 14.93B yen (YoY +1.2%). Southeast Asia and India segment revenue rose from 5.36B yen to 5.54B yen (YoY +3.4%). The metalworking fluids business, which comprises the core revenue stream across all segments, totaled 37.24B yen versus 40.41B yen prior year. The cleanliness business (formerly building maintenance) remained stable at 1.57B yen.
Operating income decreased 0.23B yen (YoY -5.7%) to 3.83B yen, with operating margin improving slightly to 9.9% from 9.7% prior year, indicating effective cost management despite revenue pressures. Segment-level profitability showed mixed trends: Japan segment operating income declined from 0.77B yen to 0.62B yen (YoY -20.0%), while North and South America improved from 2.76B yen to 2.79B yen (YoY +1.1%). China segment profit collapsed from 0.36B yen to 0.08B yen (YoY -78.0%) due to consolidation changes, and Southeast Asia and India segment profit expanded from 0.57B yen to 0.70B yen (YoY +23.2%). Segment adjustments improved from negative 0.40B yen to negative 0.36B yen, primarily reflecting goodwill and intangible asset amortization of 0.39B yen related to the Qualichem Inc. acquisition.
Ordinary income declined 0.16B yen (YoY -3.3%) to 4.85B yen, outperforming operating income due to positive non-operating income contributions. The gap between ordinary income (4.85B yen) and operating income (3.83B yen) of approximately 1.02B yen represents 2.6% of revenue, indicating meaningful contribution from financial income and equity-method investment gains. Net income increased 0.59B yen (YoY +14.7%) to 4.59B yen despite weaker operating performance, driven by extraordinary income of 1.35B yen, primarily investment securities sales gains of 1.33B yen. This non-recurring factor accounted for 3.4% of revenue and was the primary driver of bottom-line growth. The effective tax rate remained stable at approximately 27.1% (calculated as 1 minus net income divided by pretax income of 6.20B yen).
This represents a "revenue down, profit up" pattern, where top-line contraction was driven by structural consolidation changes and market headwinds, while bottom-line improvement was driven by non-recurring investment gains rather than operational improvement.
North and South America is the largest segment by revenue contribution with 16.85B yen (43.4% of total consolidated revenue), generating operating income of 2.79B yen and operating margin of 16.5%. This represents the company's core profit center with the highest margin among all segments. Japan segment contributed 14.93B yen in revenue (38.5% of total) but generated operating income of only 0.62B yen, yielding a margin of 3.9%, significantly below the company average. This indicates lower profitability in the domestic market compared to overseas operations. Southeast Asia and India segment delivered revenue of 5.54B yen (14.3% of total) with operating income of 0.70B yen and margin of 12.6%, representing solid profitability and growth momentum with YoY profit expansion of 23.2%. China segment revenue of 1.49B yen (3.8% of total) contributed minimal operating income of 0.08B yen (margin 5.3%) due to the consolidation scope change that removed two major subsidiaries from consolidated results and converted them to equity-method affiliates.
The stark margin differential between North and South America (16.5%) and Japan (3.9%) highlights geographic profitability dispersion, with overseas operations substantially outperforming the domestic base. The consolidation adjustment of negative 0.36B yen primarily reflects ongoing amortization of goodwill and intangible assets from the Qualichem acquisition, representing a structural drag on group profitability.
[Profitability] ROE of 9.8% (calculated from net profit margin 11.6%, asset turnover 0.601, and financial leverage 1.40x) indicates moderate return generation, positioned above the manufacturing industry median of 5.0% but below double-digit thresholds typically expected from high-growth companies. Operating margin of 9.9% (prior year 9.7%) demonstrates stable core profitability despite revenue headwinds, comparing favorably to the industry median of 8.3%. Net profit margin of 11.8% exceeds the industry median of 6.3%, though this reflects substantial contribution from non-recurring investment gains. [Cash Quality] Cash and deposits of 11.63B yen provide coverage of 2.02x against short-term borrowings of 5.77B yen, indicating adequate immediate liquidity. However, working capital exhibits efficiency concerns with receivables turnover of 82 days (DSO) above the industry median of 82.87 days, and inventory turnover of 104 days (DIO) near the industry median of 108.81 days. Operating working capital cycle of 186 days suggests room for improvement in cash conversion speed. [Investment Efficiency] Asset turnover of 0.601 times aligns closely with the industry median of 0.58, indicating competitive asset utilization efficiency. Return on assets of 7.1% significantly exceeds the industry median of 3.3%, driven by higher profitability margins. [Financial Health] Equity ratio of 71.4% (equity 46.23B yen divided by total assets 64.58B yen) substantially exceeds the industry median of 63.8%, reflecting conservative capitalization and strong financial stability. Current ratio of 217.2% and quick ratio of 198.6% both indicate robust short-term liquidity well above typical safety thresholds. Debt-to-equity ratio of 0.13x (interest-bearing debt of 5.82B yen divided by equity) represents minimal leverage, though short-term debt concentration at 99% of total borrowings creates refinancing risk that warrants monitoring.
Cash and deposits increased 2.31B yen YoY to 11.63B yen, representing a 24.8% expansion in liquid resources despite revenue contraction. This accumulation primarily reflects net income contribution of 4.59B yen and the impact of investment securities sales that generated 1.33B yen in gains. Working capital changes show mixed dynamics: accounts receivable increased from 7.91B yen to 8.70B yen (up 0.79B yen), indicating slower collection or sales concentration toward period-end that consumed cash. Inventories decreased marginally from 2.51B yen to 2.47B yen (down 0.04B yen), contributing modestly to cash generation. Accounts payable expanded from 6.91B yen to 7.52B yen (up 0.61B yen), reflecting effective supplier credit utilization that supported liquidity. Total equity increased from 44.97B yen to 46.23B yen (up 1.26B yen), with retained earnings growing 3.13B yen from 29.78B yen to 32.91B yen, suggesting dividends of approximately 1.46B yen were paid during the period. Investment securities holdings expanded significantly from 5.58B yen to 7.46B yen (up 1.88B yen or 33.6%), indicating active portfolio repositioning alongside the securities sales that generated extraordinary gains. Long-term borrowings decreased sharply from 0.60B yen to 0.06B yen (down 0.54B yen or 90.7%), while short-term borrowings remained elevated at 5.77B yen, creating a 99% short-term debt concentration that heightens refinancing considerations. The combination of strong cash position (11.63B yen), minimal total debt (5.82B yen), and equity expansion (46.23B yen) maintains financial flexibility, though working capital efficiency improvements remain an opportunity to accelerate cash conversion.
Ordinary income of 4.85B yen versus operating income of 3.83B yen reflects non-operating net contribution of approximately 1.02B yen, representing 2.6% of revenue. This comprises primarily financial income from interest and dividends, along with equity-method investment gains following the conversion of China subsidiaries to affiliate status. The positive non-operating contribution indicates diversified income sources beyond core operations, though sustainability depends on financial market conditions and affiliate performance. Extraordinary income of 1.35B yen, concentrated in investment securities sales gains of 1.33B yen, represents 3.4% of revenue and accounts for the entire YoY net income growth. This one-time item significantly elevates reported earnings quality concerns, as excluding this gain would result in adjusted net income of approximately 3.26B yen (assuming similar tax treatment), representing a YoY decline of 18.5% rather than the reported 14.7% increase. The reliance on portfolio transactions to achieve bottom-line growth indicates core operating momentum remains under pressure. Balance sheet changes show investment securities increased 33.6% YoY to 7.46B yen, suggesting active portfolio management with both sales and purchases occurring during the period. While treasury stock increased from 0.59B yen to 1.65B yen (up 1.06B yen), no cash flow statement is available to confirm whether this represents actual buyback activity or accounting reclassification. The substantial gap between operating profit growth (declining 5.7%) and net income growth (rising 14.7%) underscores that earnings quality is mixed, with core business facing headwinds while financial management activities support reported results.
Progress against full-year guidance shows revenue achievement at 75.8% (38.81B yen actual versus 51.20B yen forecast), operating income at 83.2% (3.83B yen versus 4.60B yen forecast), ordinary income at 85.0% (4.85B yen versus 5.70B yen forecast), and net income at 93.7% (4.59B yen versus 4.90B yen forecast). With Q3 representing 75% of the fiscal year, revenue progress of 75.8% aligns with seasonal expectations, suggesting Q4 revenue of approximately 12.39B yen is required to meet guidance. Operating income progress of 83.2% indicates stronger-than-seasonal performance through Q3, requiring Q4 operating income of 0.77B yen to achieve the 4.60B yen target, which appears achievable given Q3 run-rate. Net income progress of 93.7% substantially exceeds typical Q3 thresholds, reflecting the 1.33B yen investment securities gain recorded in the first nine months. This suggests Q4 net income of only 0.31B yen is needed to meet the 4.90B yen full-year target, implying the company may have front-loaded extraordinary gains or expects modest Q4 core earnings. The full-year guidance implies YoY changes of revenue decline of 7.8%, operating income decline of 9.2%, and ordinary income decline of 6.5%, consistent with the consolidation impact in China and challenging business conditions. Annual dividend guidance of 68 yen per share represents a payout ratio of approximately 27.6% based on forecast EPS of 370.37 yen, maintaining a conservative and sustainable distribution policy.
Annual dividend per share is guided at 68 yen for the full fiscal year, comprising an interim dividend of 30 yen already paid and an expected year-end dividend of 38 yen. This represents an increase from the prior year interim dividend, demonstrating commitment to shareholder returns despite revenue headwinds. Based on forecast net income of 4.90B yen and approximately 13.23 million shares outstanding (calculated from forecast EPS of 370.37 yen), total annual dividends would approximate 0.90B yen, yielding a payout ratio of 18.4%. However, using actual Q3 cumulative net income of 4.59B yen and assuming similar full-year earnings, the effective payout ratio would approximate 19.6%, remaining well within sustainable thresholds. The dividend policy appears conservative and cash-backed given current cash holdings of 11.63B yen and minimal debt obligations. Treasury stock increased from 0.59B yen to 1.65B yen during the period, though without cash flow detail it cannot be confirmed whether this reflects active share repurchases or accounting treatment. If share buybacks occurred, total shareholder returns would meaningfully exceed the dividend-only payout ratio, though specific buyback amounts are not disclosed in the available data. The stable dividend guidance amid declining operating performance demonstrates management prioritization of shareholder distributions and confidence in underlying cash generation capacity.
Geographic concentration risk in North and South America, which contributes 43.4% of revenue and represents the primary profit engine with 16.5% margin, creates exposure to regional economic cycles, currency fluctuations, and competitive dynamics in this market. The consolidation change in China, where two subsidiaries were converted to equity-method affiliates, introduces earnings volatility risk as affiliate results will now flow through non-operating income rather than consolidated revenue and operating profit, reducing management control and visibility. The sharp decline in China segment revenue from 4.73B yen to 1.49B yen (down 68.6%) demonstrates the magnitude of structural impact that could recur if similar consolidation changes occur in other regions. Working capital management efficiency concerns, evidenced by receivables turnover of 82 days and inventory turnover of 104 days, create cash conversion risk if customer payment behaviors deteriorate or inventory obsolescence accelerates. The combined working capital cycle of 186 days ties up significant capital that could otherwise be deployed for growth or returned to shareholders. Short-term debt concentration at 99% of total borrowings creates refinancing risk, as the company must roll over 5.77B yen of short-term debt within 12 months. While current cash of 11.63B yen provides ample coverage, adverse credit market conditions or bank relationship changes could impact borrowing terms. Reliance on investment securities transactions to achieve earnings growth, with 1.33B yen in gains representing 29.0% of net income, indicates sustainability risk as such gains are non-recurring and dependent on portfolio performance and management timing decisions. Ongoing goodwill and intangible asset amortization of 0.39B yen per quarter (1.16B yen annualized) from the Qualichem acquisition represents a structural drag on profitability, with potential impairment risk if North America business performance deteriorates below acquisition assumptions.
[Industry Position] (Reference - Proprietary Analysis) The company demonstrates profitability metrics substantially above manufacturing industry medians. ROE of 9.8% exceeds the 2025-Q3 industry median of 5.0% and positions in the upper quartile (IQR: 2.9%-8.1%), indicating superior return generation relative to sector peers. Operating margin of 9.9% compares favorably to the industry median of 8.3% (IQR: 4.8%-12.6%), placing the company in the second quartile and demonstrating competitive operational efficiency. Net profit margin of 11.8% significantly outperforms the industry median of 6.3% (IQR: 3.2%-9.0%), ranking in the top quartile, though this is partially elevated by non-recurring investment gains. ROA of 7.1% substantially exceeds the industry median of 3.3% (IQR: 1.8%-5.2%), reflecting both higher margins and effective asset utilization. Asset turnover of 0.601 times aligns closely with the industry median of 0.58 (IQR: 0.42-0.66), indicating competitive asset productivity. Financial leverage of 1.40x is notably conservative compared to the industry median of 1.53x (IQR: 1.31-1.85), consistent with the company's high equity ratio of 71.4% versus industry median of 63.8% (IQR: 49.5%-74.7%). Current ratio of 217.2% significantly exceeds the industry median of 2.84x (284%), demonstrating superior short-term liquidity positioning. Revenue growth of negative 7.5% underperforms the industry median of positive 2.7% (IQR: -1.9% to 7.9%), placing the company in the lower quartile for top-line momentum, though this is substantially explained by the China consolidation change. Receivables turnover of 82 days aligns with the industry median of 82.87 days (IQR: 68.43-115.00 days), while inventory turnover of 104 days is slightly better than the industry median of 108.81 days (IQR: 49.60-154.77 days). Overall, the company exhibits strong profitability and conservative financial positioning relative to manufacturing sector peers, with working capital efficiency in line with industry norms and top-line growth lagging due to structural factors rather than operational underperformance.
Source: Proprietary analysis of manufacturing sector (n=98 companies for 2025-Q3 metrics)
Bottom-line earnings growth of 14.7% YoY is driven primarily by non-recurring investment securities sales gains of 1.33B yen rather than operational improvement, as core operating income declined 5.7% YoY. This indicates that underlying business momentum remains challenged by consolidation changes in China and broader market conditions, with financial management activities supporting reported profitability. Investors should distinguish between recurring core earnings power and one-time contributions when evaluating earnings sustainability and forward valuation multiples.
The geographic profitability dispersion, with North and South America generating 16.5% operating margin versus Japan's 3.9% margin, highlights the company's overseas profit dependence and suggests potential for margin improvement in the domestic business. The consolidation change in China, which reduced segment revenue 68.6% through deconsolidation of two subsidiaries, represents a significant structural shift that will persist in future periods. The ongoing equity-method treatment of these affiliates means future earnings contributions will flow through non-operating income with reduced visibility and control, creating a different risk-return profile for the China business.
Financial positioning remains robust with equity ratio of 71.4% well above industry median of 63.8%, cash holdings of 11.63B yen providing 2.02x coverage of short-term debt, and minimal leverage creating substantial balance sheet capacity. However, working capital efficiency with receivables turnover of 82 days and inventory turnover of 104 days represents an opportunity for cash conversion improvement that could accelerate shareholder returns or growth investment. The conservative dividend payout ratio of approximately 19-28% (depending on calculation method) and growing retained earnings provide a strong foundation for sustainable distributions and potential future payout increases as business conditions stabilize.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.